Circulation 2022;145:e876-e94
The GLP-1 Dominance Hypothesis Some researchers believe GLP-1 agonism drives most of the weight loss benefit, with GIP adding a modest boost
Most people on the 2.4 mg dose eat 1,200 to 1,800 kcal a day
Semaglutide injections for weight loss work by binding to GLP-1 receptors in the brain, signaling fullness, which helps you feel full faster and satisfied with smaller portions, leading to weight loss
This results in increased skin laxity, leading to what is commonly referred to as Ozempic face. Or GLP-1 face When these fat pads shrink, the face may appear: More angular Less full in the cheeks or temples More hollow under the eyes More lined around the mouth and eyes For women ages 3555, these changes can appear more dramatic due to the natural collagen decline and an age-related drop in elastin